The German federal government is financing the new research center to the tune of EUR 24 million thanks to the approval of the expert committee of the German Council of Science and Humanities – which was impressed with the potential cross-regional reach of the TranslaTUM concept – and the excellent caliber of the scientists involved. The founding director of the new central institute is the renowned nuclear medicine scientist Prof. Markus Schwaiger.
TranslaTUM is part of an overarching concept which the university is implementing step-by-step. Biomedical research activities are being expanded and interlinked across all three main TUM campuses. In addition to TranslaTUM, there is the Bavarian Nuclear Magnetic Resonance Center (Garching), the TUM Center for Functional Protein Assemblies (CPA) (Garching) and the Klaus Tschira Foundation’s Multiple Sclerosis Research Center (Munich). TUM’s MUNICH SCHOOL OF BIOENGINEERING is an integrative research center that provides a common teaching and research platform for all relevant medical engineering activities across different departments, including imaging technologies.